The use of magnetic resonance in myocardial ischaemia

Acta Biomedica de l'Ateneo Parmense

Volumn 76, Issue 3, 2005, Pages

  De Filippo, Massimo ^a   Sudberry, Jonathan J ^b   Borgia, Daniele ^a   Rovani, Corrado ^a   Chernyschova, Natalya ^a   Salati, Fabio ^a   Cagnoni, Giovanni ^a   De Blasi, Mario ^a   Beghi, Cesare ^a   Zompatori, Maurizio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

MRI; Myocardial ischaemia; Myocardial viability

Indexed keywords

ALLOPATHY; BLOOD FLOW; CORONARY ARTERY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART VOLUME; INTERMETHOD COMPARISON; KINETICS; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE; REVIEW;

CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; HUMANS; KINETICS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; ORGAN SIZE; REPRODUCIBILITY OF RESULTS;

EID: 33645924072     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Dendale P, Franken PR, Block P, Pratikakis Y, De Roos A. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 1998; 135: 875-80.
2. Kwong RY, Schussheim AE, Rekhraj S, et al. Detecting Acute Coronary Syndrome in the emergency department with Cardiac Magnetic Resonance Imaging. Circulation 2003; 107: 531-7.
3. Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648-53.
4. Nagel E, Lorenz C, Baer F, et al. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 2001; 3: 267-573.
5. Lombardi M, Bartolozzi C. Risonanza Magnetica del cuore e dei vasi. Springer, 2004.
6. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001; 104: 1101-107.
7. Reichek N. MRI myocardial tagging. J Magn Reson Imaging 1999; 10: 609-16.
8. Lorenz CH, Walker ES, Moegan VL, et al. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999; 1: 7-21.
9. Kramer CM, Malkowski MJ, Mankad S, et al. Magnetic resonance tagging and echocardiographic response to dobutamine and functional improvement after reperfused myocardial infarction. Am Heart J 2002; 143: 1046-51.
10. Higgins CB, De Roos A. Cardiovascular MRI & MRA. Lippincott Williams & Wilkins, 2003.
11. Manning WJ, Atkinson DJ, Grossman W, et al. First-pass nuclear magnetic resonance imaging studies with gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 1991; 18: 959-65.
12. Matheijssen NA, Louwerenburg HW, van Rugge FP, et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detention of perfusion abnormalities in patients one vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med 1996; 35: 221-8.
13. Santarelli MF, Landini L, Lombardi M, et al. A model-based method for myocardium flow estimation. MAGNA 2000; 11: 87-8.
14. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001; 103: 2230-35.
15. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating" myocardium. J Am Coll Cardiol 1986; 8: 1467-70.
16. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and reversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-91.
17. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viabily with contrast enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002; 105: 162-7.
18. Kesavan S, Godwin C, Mohan S, Scott DF. Role of Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Viability. Circulation 2004; 109: 1328-34.
19. Elsasser A, Schlepper M, Klovekorn WP, et al. Hibernating myocardium: an incomplete adaption to ischaemia. Circulation 1997; 96: 2920-31.
20. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
21. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardium disfunction. Lancet 2001; 343: 1445-53.
22. Pereira RS, Prato FS, Wisenberg G, et al. The use of Gd-DTPA as a marker of myocardial viability in reperfused acute myocardial infarction. Int J Cardiovasc Imaging 2001; 17: 395-404.
23. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-23.
24. Wu KC, Judd RM, Vargas JD, et al. Visualization of presence, location, and transmural extent of healed Q-wave and non Q-wave myocardial infarction. Lancet 2001; 357: 21-8.
25. McNamara MT, Tccholakoff D, Revel D, et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 1986; 158: 765-9.
26. Pereira RS, Prato FS, Lekx KS, et al. Contrast-enhanced MRI for the assessment of myocardial viability after permanent coronary artery occlusion. Radiology 2000; 44: 309-16.
27. Gerber BL, Garot J, Bluemke DA, et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002; 106: 1083-9.